Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...
Following a fire at a Bayer executive’s New Jersey home earlier this month, at least eight agencies—including the Federal ...
Pharma firms are among many pausing diversity programmes and promising domestic investment ...
The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...
Trump’s demand for firms to relocate to the US could be a problem for Ireland as big pharma may be pushed to consider ...
Pfizer appoints former J&J executive to lead obesity drug development Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
PARIS] Ozempic-maker Novo Nordisk is planning to make more of its medicines for the US market in the country; Boeing risks a ...
Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...
U.S. President Donald Trump has made numerous tariff threats since returning to office on January 20, ranging from a universal duty on imports to targeted tariffs on specific sectors or ...
Mattiedna Johnson was a nurse, laboratory technician, and medical researcher who revolutionize modern antibiotic treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results